O. Lavergne et Dch. Bigg, The other camptothecins: recent advances on camptothecin analogs other than irinotecan and topotecan, B CANCER, 1998, pp. 51-58
The first part of this review summarizes the clinical developments concerni
ng camptothecin, 9-aminocamptothecin, 9-nitrocamptothecin, GG-211 and DX-89
51f: The second part covers the recent developments of research on CPT anal
ogs: CPTs with solubilizing substituents, CPTs with activating substituents
, CPTs with dual activity, CPT prodrugs and CPTs with stabilized lactones.